BPC-157 is available through medical providers who work with licensed 503A compounding pharmacies
Prescription-grade injectable peptides are regulated medications that must be custom-dosed and monitored by a healthcare professional to ensure safe and effective use
Ultimately, its best to consult a dermatologist to find the best treatment plan for you
The majority of BPC-157 research has been conducted in Wistar and Sprague-Dawley rat models, covering gastric ulcer induction (ethanol and NSAID models), Achilles tendon transection, ligament crush injuries, and various organ lesion protocols including liver, pancreas, and brain
Many adults remain stable on 1,000 mcg once monthly, though dose intervals can be adjusted according to serum markers
As of June 2026, neither compound is FDA-approved